Merit Medical Systems Inc (MMSI)
74.04
+0.66
(+0.90%)
USD |
NASDAQ |
Apr 26, 10:38
Merit Medical Systems Enterprise Value: 4.487B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.487B |
| April 24, 2024 | 4.525B |
| April 23, 2024 | 4.533B |
| April 22, 2024 | 4.479B |
| April 19, 2024 | 4.409B |
| April 18, 2024 | 4.348B |
| April 17, 2024 | 4.379B |
| April 16, 2024 | 4.450B |
| April 15, 2024 | 4.405B |
| April 12, 2024 | 4.443B |
| April 11, 2024 | 4.498B |
| April 10, 2024 | 4.404B |
| April 09, 2024 | 4.436B |
| April 08, 2024 | 4.470B |
| April 05, 2024 | 4.427B |
| April 04, 2024 | 4.403B |
| April 03, 2024 | 4.456B |
| April 02, 2024 | 4.424B |
| April 01, 2024 | 4.588B |
| March 28, 2024 | 4.624B |
| March 27, 2024 | 4.607B |
| March 26, 2024 | 4.460B |
| March 25, 2024 | 4.453B |
| March 22, 2024 | 4.425B |
| March 21, 2024 | 4.469B |
| Date | Value |
|---|---|
| March 20, 2024 | 4.459B |
| March 19, 2024 | 4.471B |
| March 18, 2024 | 4.419B |
| March 15, 2024 | 4.399B |
| March 14, 2024 | 4.403B |
| March 13, 2024 | 4.465B |
| March 12, 2024 | 4.518B |
| March 11, 2024 | 4.558B |
| March 08, 2024 | 4.592B |
| March 07, 2024 | 4.602B |
| March 06, 2024 | 4.572B |
| March 05, 2024 | 4.587B |
| March 04, 2024 | 4.668B |
| March 01, 2024 | 4.654B |
| February 29, 2024 | 4.650B |
| February 28, 2024 | 4.878B |
| February 27, 2024 | 4.898B |
| February 26, 2024 | 4.858B |
| February 23, 2024 | 4.854B |
| February 22, 2024 | 4.853B |
| February 21, 2024 | 4.825B |
| February 20, 2024 | 4.862B |
| February 16, 2024 | 4.833B |
| February 15, 2024 | 4.840B |
| February 14, 2024 | 4.828B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.543B
Minimum
Oct 31 2019
5.150B
Maximum
Jul 14 2023
3.577B
Average
3.644B
Median
Jun 04 2021
Enterprise Value Benchmarks
| Becton Dickinson & Co | 81.51B |
| Integer Holdings Corp | 4.649B |
| Abbott Laboratories | 193.05B |
| Insulet Corp | 12.19B |
| West Pharmaceutical Services Inc | 26.31B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 27.63M |
| Revenue (Quarterly) | 324.52M |
| Total Expenses (Quarterly) | 291.38M |
| EPS Diluted (Quarterly) | 0.48 |
| Gross Profit Margin (Quarterly) | 46.39% |
| Profit Margin (Quarterly) | 8.51% |
| Earnings Yield | 2.20% |
| Operating Earnings Yield | 2.91% |
| Normalized Earnings Yield | 2.238 |